Cytokinetics Inc. buy Needham & Company LLC
Start price
28.02.24
/
50%
€71.00
Target price
28.02.25
€99.73
Performance (%)
-26.76%
Price
30.08.24
€52.00
Summary
This prediction is currently active. The price of Cytokinetics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.76%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 0.971% | 0.971% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€44.80
23.05.24
23.05.24
€66.32
23.05.25
23.05.25
16.07%
30.08.24
30.08.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€59.00
09.05.24
09.05.24
€100.26
09.05.25
09.05.25
-11.86%
30.08.24
30.08.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
09.04.24
09.04.24
€99.24
09.04.25
09.04.25
-23.53%
30.08.24
30.08.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€73.50
27.12.23
27.12.23
€97.23
27.12.24
27.12.24
-29.25%
30.08.24
30.08.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€31.40
20.10.23
20.10.23
€56.68
20.10.24
20.10.24
64.01%
30.08.24
30.08.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
67.22%
05.08.24
05.08.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24